DYAI Logo

Dyadic International, Inc. (DYAI) 

NASDAQ
Market Cap
$52.82M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
644 of 960
Rank in Industry
357 of 550

Largest Insider Buys in Sector

DYAI Stock Price History Chart

DYAI Stock Performance

About Dyadic International, Inc.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other …

Insider Activity of Dyadic International, Inc.

Over the last 12 months, insiders at Dyadic International, Inc. have bought $0 and sold $0 worth of Dyadic International, Inc. stock.

On average, over the past 5 years, insiders at Dyadic International, Inc. have bought $100,266 and sold $823,692 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,670 shares for transaction amount of $16,812 was made by Rawson Ping Wang (Chief Financial Officer) on 2021‑06‑03.

List of Insider Buy and Sell Transactions, Dyadic International, Inc.

2022-07-07SaleVP of Research and Bus. Dvlpmt
1,089
0.0038%
$3.41$3,713-45.59%
2021-12-23SalePresident and CEO
28,767
0.1022%
$4.10$117,945-35.64%
2021-12-22SalePresident and CEO
35,649
0.1276%
$4.12$146,874-35.37%
2021-12-21SalePresident and CEO
26,486
0.0937%
$4.33$114,684-39.22%
2021-06-09SalePresident and CEO
23,000
0.0839%
$3.72$85,560+1.08%
2021-06-08SalePresident and CEO
30,000
0.1074%
$3.82$114,600-3.37%
2021-06-07SalePresident and CEO
44,000
0.1604%
$3.95$173,800-4.59%
2021-06-04SalePresident and CEO
132,000
0.48%
$3.85$508,200-2.22%
2021-06-03SalePresident and CEO
26,721
0.0969%
$3.61$96,463+4.17%
2021-06-03PurchaseChief Financial Officer
4,670
0.0169%
$3.60$16,812+4.17%
2021-06-02SalePresident and CEO
76,349
0.2814%
$3.74$285,545+2.18%
2021-06-02PurchaseChief Financial Officer
22,330
0.0823%
$3.74$83,454+2.18%
2019-12-11SaleVP of Research and Bus. Dvlpmt
4,575
0.0167%
$5.80$26,535+8.48%
2019-12-10SaleVP of Research and Bus. Dvlpmt
5,425
0.0201%
$5.84$31,682+9.23%
2019-12-03Saledirector
15,000
0.0546%
$6.18$92,700+1.13%
2019-11-11SaleVP of Research and Bus. Dvlpmt
10,000
0.0366%
$5.99$59,900+3.69%
2019-10-11SaleVP of Research and Bus. Dvlpmt
10,436
0.0356%
$6.08$63,451-6.00%
2019-10-10SaleVP of Research and Bus. Dvlpmt
9,564
0.0219%
$3.73$35,626+3.12%
2019-09-10SaleVP of Research and Bus. Dvlpmt
20,000
0.0463%
$3.34$66,800+14.12%
2019-08-13SaleVP of Research and Bus. Dvlpmt
12,600
0.0437%
$5.75$72,450-1.31%

Insider Historical Profitability

3.17%
KITT BARRY M10 percent owner
1959172
6.6212%
$1.79120
Rawson Ping WangChief Financial Officer
35850
0.1212%
$1.7920+3.17%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Bandera Partners LLC$2.62M5.361.57M0%+$01.15
Chapin Davis Inc$1.38M2.83826,3010%+$00.51
The Vanguard Group$1.34M2.75804,038+0.01%+$202.07<0.0001
NORTHEAST FINANCIAL CONSULTANTS, INC$417,500.000.86250,0000%+$00.02
BlackRock$413,262.000.85247,462-0.46%-$1,923.84<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.